British Journal of Cancer - Table of Contents alert Volume 109 Issue 11

TABLE OF CONTENTS Volume 109, Issue 11 (2763-2950) Published online 26 November 2013 In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press?  Leukaemia in young children in the vicinity of British nuclear power plants: a case-control study J F Bithell, M F G Murphy et al.  Editorial Top Childhood leukaemia near nuclear power plants C R Muirhead Br J Cancer 2013 109: 2763-2764; 10.1038/bjc.2013.674 Full Text Clinical Studies Top Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy S K M Spencer, A J C Pommier, S R Morgan, S T Barry, J D Robertson, P M Hoff and J M Jürgensmeier Br J Cancer 2013 109: 2765-2773; advance online publication, October 22, 2013; 10.1038/bjc.2013.649 Abstract | Full Text External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours S Bendifallah, C Uzan, R Fauvet, P Morice and E Darai Br J Cancer 2013 109: 2774-2777; advance online publication, October 29, 2013; 10.1038/bjc.2013.678 Abstract | Full Text Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China D Y Cao, J X Yang, X H Wu, Y L Chen, L Li, K J Liu, M H Cui, X Xie, Y M Wu, B H Kong, G H Zhu, Y Xiang, J H Lang and K Shen China Gynecologic Oncology Group Br J Cancer 2013 109: 2778-2782; advance online publication, October 29, 2013; 10.1038/bjc.2013.656 Abstract | Full Text Impact of sentinel node biopsy on long-term quality of life in breast cancer patients E De Gournay, A Guyomard, C Coutant, S Boulet, P Arveux, S Causeret, S Gouy, M-M Padeano, C Loustalot, J-M Sauzedde, M Smail, J-P Combier, P Chevillote, C Rosburger, F Bonnetain, J Fraisse and T S Dabakuyo-Yonli Br J Cancer 2013 109: 2783-2791; advance online publication, October 29, 2013; 10.1038/bjc.2013.658 Abstract | Full Text The effect of metformin on apoptosis in a breast cancer presurgical trial M Cazzaniga, A DeCensi, G Pruneri, M Puntoni, L Bottiglieri, C Varricchio, A Guerrieri-Gonzaga, O D Gentilini, G Pagani, P Dell'Orto, M Lazzeroni, D Serrano, G Viale and B Bonanni Br J Cancer 2013 109: 2792-2797; advance online publication, October 24, 2013; 10.1038/bjc.2013.657 Abstract | Full Text Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer? A Evans, S Armstrong, P Whelehan, K Thomson, P Rauchhaus, C Purdie, L Jordan, L Jones, A Thompson and S Vinnicombe Br J Cancer 2013 109: 2798-2802; advance online publication, October 29, 2013; 10.1038/bjc.2013.660 Abstract | Full Text CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer N Yamamoto, H Murakami, H Hayashi, Y Fujisaka, T Hirashima, K Takeda, M Satouchi, K Miyoshi, S Akinaga, T Takahashi and K Nakagawa Br J Cancer 2013 109: 2803-2809; advance online publication, October 29, 2013; 10.1038/bjc.2013.588 Abstract | Full Text Translational Therapeutics Top Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine K Bijian, C Lougheed, J Su, B Xu, H Yu, J H Wu, K Riccio and M A Alaoui-Jamali Br J Cancer 2013 109: 2810-2818; advance online publication, October 29, 2013; 10.1038/bjc.2013.675 Abstract | Full Text Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects A K Ferreira, B A A Santana-Lemos, E M Rego, O M R Filho, G O Chierice and D A Maria Br J Cancer 2013 109: 2819-2828; advance online publication, November 7, 2013; 10.1038/bjc.2013.510 Abstract | Full Text Molecular Diagnostics Top Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer M Iwatsuki, K Toyoshima, M Watanabe, N Hayashi, T Ishimoto, K Eto, S Iwagami, Y Baba, N Yoshida, A Hayashi, Y Ohta and H Baba Br J Cancer 2013 109: 2829-2832; advance online publication, November 7, 2013; 10.1038/bjc.2013.680 Abstract | Full Text Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations L Heinzerling, M Baiter, S Kühnapfel, G Schuler, P Keikavoussi, A Agaimy, F Kiesewetter, A Hartmann and R Schneider-Stock Br J Cancer 2013 109: 2833-2841; advance online publication, November 5, 2013; 10.1038/bjc.2013.622 Abstract | Full Text ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients J Lu, Y Tang, Y Cheng, G Zhang, A Yip, M Martinka, Z Dong, J Zhou and G Li Br J Cancer 2013 109: 2842-2852; advance online publication, October 24, 2013; 10.1038/bjc.2013.670 Abstract | Full Text MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways N Wu, X Lin, X Zhao, L Zheng, L Xiao, J Liu, L Ge and S Cao Br J Cancer 2013 109: 2853-2863; advance online publication, October 29, 2013; 10.1038/bjc.2013.672 Abstract | Full Text Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia P Nankivell, H Williams, C McConkey, K Webster, A High, K MacLennan, B Senguven, P Rabbitts and H Mehanna Br J Cancer 2013 109: 2864-2874; advance online publication, November 7, 2013; 10.1038/bjc.2013.600 Abstract | Full Text Epidemiology Top Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening A Gentry-Maharaj, E-O Fourkala, M Burnell, A Ryan, S Apostolidou, M Habib, A Sharma, M Parmar, I Jacobs and U Menon Br J Cancer 2013 109: 2875-2879; advance online publication, October 15, 2013; 10.1038/bjc.2013.626 Abstract | Full Text Leukaemia in young children in the vicinity of British nuclear power plants: a case–control study J F Bithell, M F G Murphy, C A Stiller, E Toumpakari, T Vincent and R Wakeford Br J Cancer 2013 109: 2880-2885; advance online publication, September 12, 2013; 10.1038/bjc.2013.560 Abstract | Full Text Leukaemia incidence in the Techa River Cohort: 1953–2007 L Y Krestinina, F G Davis, S Schonfeld, D L Preston, M Degteva, S Epifanova and A V Akleyev Br J Cancer 2013 109: 2886-2893; advance online publication, October 15, 2013; 10.1038/bjc.2013.614 Abstract | Full Text The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis S S Zhang, H Yang, K J Luo, Q Y Huang, J Y Chen, F Yang, X L Cai, X Xie, Q W Liu, A E Bella, R G Hu, J Wen, Y Hu and J H Fu Br J Cancer 2013 109: 2894-2903; advance online publication, November 7, 2013; 10.1038/bjc.2013.666 Abstract | Full Text Foods, nutrients and the risk of oral and pharyngeal cancer F Bravi, C Bosetti, M Filomeno, F Levi, W Garavello, S Galimberti, E Negri and C La Vecchia Br J Cancer 2013 109: 2904-2910; advance online publication, October 22, 2013; 10.1038/bjc.2013.667 Abstract | Full Text Nut consumption and risk of pancreatic cancer in women Y Bao, F B Hu, E L Giovannucci, B M Wolpin, M J Stampfer, W C Willett and C S Fuchs Br J Cancer 2013 109: 2911-2916; advance online publication, October 22, 2013; 10.1038/bjc.2013.665 Abstract | Full Text Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden J Huang, M Magnusson, A Törner, W Ye and A-S Duberg Br J Cancer 2013 109: 2917-2923; advance online publication, October 31, 2013; 10.1038/bjc.2013.689 Abstract | Full Text Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands P Eijgenraam, M M Heinen, B A J Verhage, Y C Keulemans, L J Schouten and P A van den Brandt Br J Cancer 2013 109: 2924-2932; advance online publication, October 22, 2013; 10.1038/bjc.2013.629 Abstract | Full Text Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: a nationwide cohort study in Taiwan Y-C Lien, J-Y Wang, M-C Lee, C-C Shu, H-Y Chen, C-H Hsieh, C-H Lee, L-N Lee and K-M Chao Br J Cancer 2013 109: 2933-2940; advance online publication, October 15, 2013; 10.1038/bjc.2013.538 Abstract | Full Text Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland M K Leinonen, A Anttila, N Malila, J Dillner, O Forslund and P Nieminen Br J Cancer 2013 109: 2941-2950; advance online publication, October 17, 2013; 10.1038/bjc.2013.647 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.